2019 ICD-10-CM Diagnosis Code D3A.8

Other benign neuroendocrine tumors

    2016 2017 2018 2019 Billable/Specific Code
  • D3A.8 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2019 edition of ICD-10-CM D3A.8 became effective on October 1, 2018.
  • This is the American ICD-10-CM version of D3A.8 - other international versions of ICD-10 D3A.8 may differ.
Applicable To
  • Neuroendocrine tumor NOS
The following code(s) above D3A.8 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
  • Applicable To annotations, or
  • Code Also annotations, or
  • Code First annotations, or
  • Excludes1 annotations, or
  • Excludes2 annotations, or
  • Includes annotations, or
  • Note annotations, or
  • Use Additional annotations
that may be applicable to D3A.8:
  • C00-D49
    2019 ICD-10-CM Range C00-D49

    Neoplasms

    Note
    • Functional activity
    • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
    • Morphology [Histology]
    • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
    • Primary malignant neoplasms overlapping site boundaries
    • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
    • Malignant neoplasm of ectopic tissue
    • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
    Neoplasms
  • D3A
    ICD-10-CM Diagnosis Code D3A

    Benign neuroendocrine tumors

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Code Also
    • any associated multiple endocrine neoplasia [MEN] syndromes (E31.2-)
    Type 2 Excludes
    • benign pancreatic islet cell tumors (D13.7)
    Use Additional
    • code to identify any associated endocrine syndrome, such as:
    • carcinoid syndrome (E34.0)
    Benign neuroendocrine tumors
Approximate Synonyms
  • Benign adenoma of middle ear
  • Benign neuroendocrine adenoma of middle ear
  • Benign neuroendocrine tumor bronchus
  • Benign neuroendocrine tumor large intestine
  • Benign neuroendocrine tumor lung
  • Benign neuroendocrine tumor of appendix
  • Benign neuroendocrine tumor of ascending colon
  • Benign neuroendocrine tumor of bilateral kidneys
  • Benign neuroendocrine tumor of bronchus
  • Benign neuroendocrine tumor of cecum
  • Benign neuroendocrine tumor of descending colon
  • Benign neuroendocrine tumor of duodenum
  • Benign neuroendocrine tumor of ileum
  • Benign neuroendocrine tumor of jejunum
  • Benign neuroendocrine tumor of large intestine
  • Benign neuroendocrine tumor of left kidney
  • Benign neuroendocrine tumor of liver
  • Benign neuroendocrine tumor of lung
  • Benign neuroendocrine tumor of pancreas
  • Benign neuroendocrine tumor of rectum
  • Benign neuroendocrine tumor of right kidney
  • Benign neuroendocrine tumor of sigmoid colon
  • Benign neuroendocrine tumor of small intestine
  • Benign neuroendocrine tumor of stomach
  • Benign neuroendocrine tumor of thymus
  • Benign neuroendocrine tumor of transverse colon
  • Benign neuroendocrine tumor stomach
  • Benign neuroendocrine tumor thymus
  • Benign neuroendocrine tumor, appendix
  • Benign neuroendocrine tumor, ascending colon
  • Benign neuroendocrine tumor, bilateral kidneys
  • Benign neuroendocrine tumor, cecum
  • Benign neuroendocrine tumor, descending colon
  • Benign neuroendocrine tumor, duodenum
  • Benign neuroendocrine tumor, ileum
  • Benign neuroendocrine tumor, jejunum
  • Benign neuroendocrine tumor, liver
  • Benign neuroendocrine tumor, pancreas
  • Benign neuroendocrine tumor, rectum
  • Benign neuroendocrine tumor, sigmoid colon
  • Benign neuroendocrine tumor, small intestine
  • Benign neuroendocrine tumor, transverse colon
Clinical Information
  • A benign or malignant neoplasm composed of cells of neuroendocrine origin. Representative examples include paraganglioma, carcinoid tumor, and neuroendocrine carcinoma.
  • A neoplasm composed of cells of neuroendocrine origin for which the malignancy status has not been established.
  • A tumor that forms from cells that release hormones in response to a signal from the nervous system. Some examples of neuroendocrine tumors are carcinoid tumors, islet cell tumors, medullary thyroid carcinomas, pheochromocytomas, and neuroendocrine carcinomas of the skin (merkel cell cancer). These tumors may secrete higher-than-normal amounts of hormones, which can cause many different symptoms.
  • Tumors whose cells possess secretory granules and originate from the neuroectoderm, i.e., the cells of the ectoblast or epiblast that program the neuroendocrine system. Common properties across most neuroendocrine tumors include ectopic hormone production (often via apud cells), the presence of tumor-associated antigens, and isozyme composition.
ICD-10-CM D3A.8 is grouped within Diagnostic Related Group(s) (MS-DRG v36.0):
  • 826 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedure with mcc
  • 827 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedure with cc
  • 828 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedure without cc/mcc
  • 829 Myeloproliferative disorders or poorly differentiated neoplasms with other procedure with cc/mcc
  • 830 Myeloproliferative disorders or poorly differentiated neoplasms with other procedure without cc/mcc
  • 843 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses with mcc
  • 844 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses with cc
  • 845 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses without cc/mcc

Convert D3A.8 to ICD-9-CM

Code History
  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change

Diagnosis Index entries containing back-references to D3A.8:

ICD-10-CM Codes Adjacent To D3A.8
D3A.029 Benign carcinoid tumor of the large intestine, unspecified portion
D3A.09 Benign carcinoid tumors of other sites
D3A.090 Benign carcinoid tumor of the bronchus and lung
D3A.091 Benign carcinoid tumor of the thymus
D3A.092 Benign carcinoid tumor of the stomach
D3A.093 Benign carcinoid tumor of the kidney
D3A.094 Benign carcinoid tumor of the foregut, unspecified
D3A.095 Benign carcinoid tumor of the midgut, unspecified
D3A.096 Benign carcinoid tumor of the hindgut, unspecified
D3A.098 Benign carcinoid tumors of other sites
D3A.8 Other benign neuroendocrine tumors
D37 Neoplasm of uncertain behavior of oral cavity and digestive organs
D37.0 Neoplasm of uncertain behavior of lip, oral cavity and pharynx
D37.01 Neoplasm of uncertain behavior of lip
D37.02 Neoplasm of uncertain behavior of tongue
D37.03 Neoplasm of uncertain behavior of the major salivary glands
D37.030 Neoplasm of uncertain behavior of the parotid salivary glands
D37.031 Neoplasm of uncertain behavior of the sublingual salivary glands
D37.032 Neoplasm of uncertain behavior of the submandibular salivary glands
D37.039 …… unspecified
D37.04 Neoplasm of uncertain behavior of the minor salivary glands

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.